HCV NS4A PROTEIN (21-34) (JT STRAIN)

CAS176260-88-1

HCV NS4A PROTEIN (21-34) (JT STRAIN) (CAS 176260-88-1, C63H116 N20 O17) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of HCV NS4A PROTEIN (21-34) (JT STRAIN)
C63H116 N20 O17 · 1425.7 g/mol
CAS No.
176260-88-1
Formula
C63H116 N20 O17
Mol. weight
1425.7 g/mol

Chemical Specifications

Identifiers

CAS number 176260-88-1
Product name HCV NS4A PROTEIN (21-34) (JT STRAIN)
Synonyms H-GLY-SER-VAL-VAL-ILE-VAL-GLY-ARG-ILE-ILE-LEU-SER-GLY-ARG-OH
Molecular formula C63H116 N20 O17
Molecular weight 1425.7 g/mol

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of HCV NS4A PROTEIN (21-34) (JT STRAIN)?

The CAS Registry Number of HCV NS4A PROTEIN (21-34) (JT STRAIN) is 176260-88-1. HCV NS4A PROTEIN (21-34) (JT STRAIN) is also known as H-GLY-SER-VAL-VAL-ILE-VAL-GLY-ARG-ILE-ILE-LEU-SER-GLY-ARG-OH.

What is the molecular formula and molecular weight of HCV NS4A PROTEIN (21-34) (JT STRAIN)?

The molecular formula of HCV NS4A PROTEIN (21-34) (JT STRAIN) is C63H116 N20 O17, and its molecular weight is 1425.7 g/mol.

How can I request a quotation for HCV NS4A PROTEIN (21-34) (JT STRAIN)?

Send an inquiry for HCV NS4A PROTEIN (21-34) (JT STRAIN) (CAS 176260-88-1) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for HCV NS4A PROTEIN (21-34) (JT STRAIN)

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.